AMA Adopts Resolution Introduced by The Endocrine Society Calling for FDA Oversight of Bioidentical Hormones
16th Nov 2006, 08:21 GMT
The AMA 's House of Delegates unanimously and enthusiastically passed a resolution introduced by The Endocrine Society and other concerned organizations urging the US FDA to increase its oversight and regulation of so-called bioidentical hormones.
AMA Adopts Resolution Introduced by The Endocrine Society Calling for FDA Oversight of Bioidentical Hormones related news:
- AMA Adopts Resolution Introduced By The Endocrine Society Calling for FDA Oversight of Bioidentical Hormones — RedOrbit News - Health
- Harris County Medical Society earns AMA citation — Latest news from Houston Business Journal
- AMA Honors Kansas Medical Society Executive — Kansas City infoZine Health Headlines
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System — FDA News News from StratCenter.com
- AMA Adopts Plan to Help Protect Children from Online Harm — ArriveNet : Politics
- AMA Adopts New Policies on Mercury Pollution, Hormone Compounds and Smoke-Free Meetings — ArriveNet : Politics
- Sex hormones impact stress hormones — United Press International - Consumer Health
- Meeting In Helsinki On Impacts Of Endocrine Disrupters: More Knowledge Needed On Chemical Synergism — Health News from Medical News Today
- Sports Cheats Beware -- New Test Detects Previously Undetectable Drug — ScienceDaily Headlines
- FermaVir's Founder and Board Member Professor Chris McGuigan receives the Royal Society of Chemistry's Award for Medicinal Chemistry — FDA News News from StratCenter.com
Latest news from FDA News News from StratCenter.com:
- North American Gets Cancer Treatment OK
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ.
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step
- Ivax Diagnostics Delays Filing 3Q Report
- New Corporate Members and Leaders for C-Path's Predictive Safety Testing Consortium Announced
- Diagnosoft Receives FDA Approval for Cardiac MRI Quantitative Regional Function Software Based on the HARP Technology
- PAREXEL Consulting Expands Risk Mgmt Expertise, Appoints Former FDA Consumer Safety Officer Raymond T Oji as Senior Consultant
- Trubion Pharmaceuticals to Present at the Lazard Life Sciences Conference
- Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting